The utility of non-invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma

Br J Haematol. 2020 Apr;189(2):e45-e48. doi: 10.1111/bjh.16440. Epub 2020 Mar 19.
No abstract available

Keywords: circulating tumor DNA; droplet digital PCR; extramedullary myeloma; liquid biopsy; targeted next-generation sequencing.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Liquid Biopsy / methods*
  • Male
  • Middle Aged
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / pathology
  • Multiple Myeloma / surgery
  • Neoplasm, Residual / surgery*